Prescribing and dispensing guidelines for medicinal drugs affecting driving performance
- Johan J. de GierAffiliated withUniversity of Groningen, Department of Pharmacotherapy and Pharmaceutical Care
- , F. Javier AlvarezAffiliated withPharmacology and Therapeutics, Faculty of Medicine, University of Valladolid
- , Charles Mercier-GuyonAffiliated withCERMT (Centre d’Études et de Recherches en Médecine du Traffic)
- , Alain G. VerstraeteAffiliated withDepartment of Clinical Chemistry, Microbiology and Immunology, Ghent University, Belgium, Laboratory of Clinical Biology — Toxicology, Ghent University Hospital
This chapter aims to provide practice-oriented information for prescribing physicians and dispensing pharmacists who want to provide their patients with adequate advice based on a clear understanding of the risks of accident involvement under different treatment conditions. Specific attention will be given to the application of a graded-level warning system based on categorization systems for psychotropic medicines that have been introduced,, and sometimes legally implemented, in several European countries. This warning system allows physicians and pharmacists to select the least impairing medicines within a therapeutic class. Advice for the patient based on three categories has been described in clear instructions, allowing the patient to make the right decision.
For the most frequently used drug classes (antihistamines, antidepressants, hypnotics and tranquillizers) information will be provided on drugs with little or no impairment within the respective classes, and risk factors (e.g. liver and./or renal dysfunction, drug-drug interactions) that might increase impairing effects. If drugs with little or no impairment can not be prescribed, specific patient information will focus on recognizing signs of impaired performance.
- Prescribing and dispensing guidelines for medicinal drugs affecting driving performance
- Book Title
- Drugs, Driving and Traffic Safety
- pp 121-134
- Print ISBN
- Online ISBN
- Birkhäuser Basel
- Copyright Holder
- Birkhäuser Verlag/Switzerland
- Additional Links
- Industry Sectors
- eBook Packages
- Editor Affiliations
- 1. Utrecht University Faculty of Science Section Psychopharmacology, Utrecht Institute for Pharmaceutical Sciences
- 2. Somnogen Inc.
- 3. Experimental Psychopharmacology Unit, Department of Neuropsychology & Psychopharmacology Faculty of Psychology and Neurosciences, Maastricht University
- 4. Department of Pharmacotherapy and Pharmaceutical Care, University of Groningen
- Author Affiliations
- 5. University of Groningen, Department of Pharmacotherapy and Pharmaceutical Care, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands
- 6. Pharmacology and Therapeutics, Faculty of Medicine, University of Valladolid, c/Ramón y Cajal 5, 47005, Valladolid, Spain
- 7. CERMT (Centre d’Études et de Recherches en Médecine du Traffic), BP 132, 74007, Annecy, Cedex, France
- 8. Department of Clinical Chemistry, Microbiology and Immunology, Ghent University, Belgium, Laboratory of Clinical Biology — Toxicology, Ghent University Hospital, De Pintelaan 185, B-9000, Ghent, Belgium
To view the rest of this content please follow the download PDF link above.